HeartSciences Receives FDA Breakthrough Device Designation for MyoVista Insights AI-ECG Algorithm for Detecting Aortic Stenosis

Stock Information for HeartSciences Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About HeartSciences Inc.

Foundational US Patent Granted for ECG Assessment of Heart Function, Further Expands HeartSciences' Patent Portfolio and IP Value
HeartSciences Signs First MyoVista Insights(TM) Platform Customer, Marking Major Commercial Milestone
HeartSciences' CEO Andrew Simpson to Present at Emerging Growth Conference 82 on Wednesday, May 21, 2025
Presenting on Emerging Growth Conference 82 Day 1 on May 21; Register to live stream
HeartSciences to Host Investor Webinar and Q&A on Wednesday May 14, 2025 - Featuring CEO Andrew Simpson
HeartSciences Adds Prominent Key Advisors to its Scientific Advisory Board
HeartSciences Announces Launch of MyoVista Insights(TM) Platform and Related Early Adopter Program
HeartSciences Provides Business Update and Reports Third Quarter Fiscal 2025 Financial Results

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.